(19)
(11) EP 4 163 006 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
20.03.2024 Bulletin 2024/12

(45) Mention of the grant of the patent:
31.01.2024 Bulletin 2024/05

(21) Application number: 21201916.0

(22) Date of filing: 11.10.2021
(51) International Patent Classification (IPC): 
B01F 25/23(2022.01)
B01F 25/10(2022.01)
B01F 35/10(2022.01)
 B01F 25/43(2022.01)
B01F 23/41(2022.01)
(52) Cooperative Patent Classification (CPC):
B01F 25/23; B01F 25/43; B01F 25/10; B01F 23/41; B01F 2215/0404; B01F 35/10

(54)

METHODS FOR VALIDATING AN APPARATUS FOR PRODUCING NANOPARTICLES

VERFAHREN ZUR VALIDIERUNG EINER VORRICHTUNG ZUR HERSTELLUNG VON NANOPARTIKELN

PROCÉDÉS DE VALIDATION D'UN APPAREIL DE PRODUCTION DE NANOPARTICULES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(43) Date of publication of application:
12.04.2023 Bulletin 2023/15

(73) Proprietor: leon-nanodrugs GmbH
82152 Planegg (DE)

(72) Inventors:
  • CLEMENT, Pascale
    81679 Munich (DE)
  • LÓPEZ-SÁNCHEZ, Beatriz
    81679 Munich (DE)

(74) Representative: Pharma Patents International AG 
Leonhardsgraben 52 Postfach
4001 Basel
4001 Basel (CH)


(56) References cited: : 
WO-A2-01/34113
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).